Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EASY trial of oral versus parenteral antibiotics for possible urinary tract infection in young febrile infants
ISRCTN10907780Phase 3Terminated
- Sponsor
- Belfast Health and Social Care Trust
- Start
- May 2024
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
01
Overview
Phase 3, randomised, open-label trial of cefalexin, amoxicillin + clavulanate, trimethoprim, ceftriaxone, cefotaxime and 3 more in urinary tract infection (UTI) (2 arms), sponsored by Belfast Health and Social Care Trust. Primary endpoint: Treatment failure within 7 days. Started May 2024; status: terminated.
02
Drugs
cefalexinamoxicillin + clavulanatetrimethoprimceftriaxonecefotaxime
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on ISRCTN10907780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN10907780.